In this presentation, we welcome Aytu BioPharma, NASDAQ symbol AYTU, and with us today is their Chief Executive Officer, Josh Disbrow. Aytu BioPharma is a pharmaceutical company commercializing a portfolio of commercial prescription therapeutics.

This Fireside Chat was recorded during the Lytham Partners Spring 2023 Investor Conference.